logo
Leveragen Announces Strategic Collaboration with Moonlight Bio to Advance T Cell Therapies Using Proprietary Fully Human Single-Domain Antibody Technology

Leveragen Announces Strategic Collaboration with Moonlight Bio to Advance T Cell Therapies Using Proprietary Fully Human Single-Domain Antibody Technology

WOBURN, Mass.--(BUSINESS WIRE)--Jan 29, 2025--
Leveragen Inc., a Boston-based biotech company specializing in next-generation genetic models for antibody discovery, today announced a strategic collaboration with Moonlight Bio, a Seattle-based biotech company pioneering advanced T cell therapies. This partnership aims to develop cutting-edge T cell therapies to address some of the most challenging and difficult-to-treat cancers.
This press release features multimedia. View the full release here:
Leveragen Announces Strategic Collaboration with Moonlight Bio to Advance T Cell Therapies. The collaboration integrates Leveragen's proprietary Singularity Sapiens Mouse platform, a groundbreaking tool for generating fully human single-domain antibodies, with Moonlight Bio's expertise in T cell engineering. Together, the two companies seek to create T cell therapies with enhanced functionality, persistence, and efficacy, overcoming significant barriers in the treatment of solid tumors. (Graphic: Business Wire)
The collaboration integrates Leveragen's proprietary Singularity Sapiens Mouse platform, a groundbreaking tool for generating fully human single-domain antibodies, with Moonlight Bio's expertise in T cell engineering. Together, the two companies seek to create T cell therapies with enhanced functionality, persistence, and efficacy, overcoming significant barriers in the treatment of solid tumors.
'Leveragen's mission is to drive innovation in the fight against life-threatening diseases, and expanding our fully human single-domain antibody technology into transformative T cell therapies aligns seamlessly with this vision,' said Weisheng Chen, Founder and CEO of Leveragen. 'Through this partnership with Moonlight Bio, we are combining our state-of-the-art antibody discovery platform with their advanced cell engineering capabilities to develop T cell therapies that have the potential to make a meaningful difference for patients.'
'At Moonlight Bio, we are dedicated to delivering T cell therapies that break through barriers obstructing successful outcomes in solid tumors – the vast majority of the global cancer disease burden,' said Jordan Jarjour, Moonlight Bio's CSO. 'Leveragen's Singularity Sapiens Mouse platform is a powerful tool for generating fully human single-domain antibodies with properties that could optimally translate into advanced T cell therapies, particularly when combined with the tools and technologies that the Moonlight Bio team is advancing. We are very excited to collaborate with Leveragen as we explore and create new solutions in this space.'
Under the terms of the agreement, Leveragen will spearhead the discovery of fully human single-domain antibodies against therapeutic targets and Moonlight Bio will oversee the preclinical development of T cell therapies.
This collaboration highlights Leveragen's leadership in single-domain antibody discovery and its commitment to advancing immunotherapy through innovative science and transformative applications.
About Leveragen
Leveragen is a genetic engineering company at the forefront of developing next-generation models for antibody discovery and biologics innovation. Leveragen's flagship platform, the Singularity Sapiens Mouse, is designed to produce heavy chain-only antibodies from the entire human VH repertoire precisely integrated into the mouse genome. By eliminating conventional antibody interference and faithfully replicating human immunoglobulin gene expression, the platform optimizes B cell development and generates robust immune responses, enabling the efficient derivation of fully human single-domain antibodies with unsurpassed diversity, affinity, and developability. This proprietary platform accelerates the discovery and development of diverse therapeutic modalities, including bispecifics, ADCs, CAR T, and mRNA-based treatments. Headquartered in Woburn, Massachusetts, Leveragen collaborates with global pharmaceutical and biotechnology leaders to drive next-generation therapeutic development. For more information, visit http://www.leveragen.com.
About Moonlight Bio
Moonlight Bio, Inc. is a preclinical-stage biotechnology company based in Seattle, WA aiming to develop potency enhanced T cell therapies that provide new hope for patients suffering from cancer. Moonlight's core technologies were illuminated by nature itself and are designed to confront the disappointing reality that therapies for solid tumors are simply not potent enough to generate the deep and durable responses that patients urgently need. To learn more, connect with Moonlight Bio on LinkedIn and visit us at http://www.moonlightbio.us/.
SOURCE: Leveragen Inc.
Copyright Business Wire 2025.
PUB: 01/29/2025 08:08 AM/DISC: 01/29/2025 08:08 AM
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Lexington Bakes Raises $1-Million Seed Round
Lexington Bakes Raises $1-Million Seed Round

Los Angeles Times

time18 minutes ago

  • Los Angeles Times

Lexington Bakes Raises $1-Million Seed Round

Los Angeles-based Lexington Bakes raised $1 million in a seed round led by Rainfall Ventures with participation from angel investors, according to the company. Company founder Lex Evan attributed the fundraising success to the company's recent launch of chilled oat bars that are distributed through San Francisco-based online grocer Good Eggs for the past two months. 'Sprouted oats become easy to digest and provide more nutrients. They have no refined sugar and contain 50% less sugar than our indulgent treats. With this new platform, we expand the space our brand holds in consumers' minds to become not only a dessert treat but also a breakfast treat to start every day with good taste,' said Evan, in a statement. The oat bars were inspired by British flapjacks and are formulated with sprouted oats, maple syrup, brown butter, dates, vanilla and salt,' Evan said. The first two flavors to launch included maple brown butter and raspberry crumble. 'We're focusing on growing our DTC (direct-to-consumer) business, and we've been able to hire a lot of help part-time and agency support,' said Evan. The funds also will support the startup's transition from self-manufacturing to co-manufacturing. Information for this article was sourced from Lexington Bakes.

Otter Tail Corporation Announces Second Quarter Earnings and Increases Annual Earnings Guidance
Otter Tail Corporation Announces Second Quarter Earnings and Increases Annual Earnings Guidance

Business Wire

time18 minutes ago

  • Business Wire

Otter Tail Corporation Announces Second Quarter Earnings and Increases Annual Earnings Guidance

FERGUS FALLS, Minn.--(BUSINESS WIRE)--Otter Tail Corporation (Nasdaq: OTTR) today announced financial results for the quarter ended June 30, 2025. SUMMARY Produced diluted earnings per share of $1.85 in the second quarter of 2025. Increased midpoint of 2025 earnings per share guidance by $0.38 to $6.26 per share. Return on equity of 17% over the trailing twelve months. CEO OVERVIEW 'We are pleased with our second quarter financial results,' said President and CEO Chuck MacFarlane. 'Across our businesses, our team members remain committed to our mission - delivering value through building strong electric and manufacturing platforms - amidst dynamic market conditions. "During the second quarter, severe weather moved through Otter Tail Power's service territory, resulting in significant property and infrastructure damage, as well as tree loss. Approximately 30 percent of our customers experienced an interruption in electric service due to the storms. Our employees worked tirelessly to restore power to our customers as quickly and safely as possible. 'Beyond our storm response, Otter Tail Power continues to perform well, executing on our significant capital investment plan and regulatory priorities. We secured approval to directly assign and recover the capital investment for our two solar development projects from the Minnesota and South Dakota Commissions. We look forward to adding 345 MW of cost-effective solar generation to our portfolio to better serve our customers. Additionally, for the first time since 2018, we filed a request with the South Dakota Public Utilities Commission for permission to increase our electric rates by approximately $5.7 million. 'Our Manufacturing segment continues to navigate soft end market demand but remains well positioned to respond when market conditions improve. Our recently completed BTD Georgia facility is ramping up to full production capability and we look forward to being able to better serve our growing customers in the southeast. 'Plastics segment results outpaced our expectations for the second quarter. We continue to benefit from strong product demand and higher sales volumes as the sales prices of PVC pipe continue to recede. 'We are uplifting our 2025 diluted earnings per share guidance for the Plastics segment, increasing our consolidated guidance to a range of $6.06 to $6.46 from our previous range of $5.68 to $6.08. 'Our strategic diversification continues to serve us and our stakeholders well even as we return to more normalized levels of Plastics segment earnings, generating incremental cash for us to reinvest into our significant utility rate base growth plan. We remain confident in our ability to deliver on our investment targets, producing an earnings per share growth of 6 to 8 percent.' QUARTERLY DIVIDEND On August 4, 2025, the corporation's Board of Directors declared a quarterly common stock dividend of $0.525 per share. This dividend is payable September 10, 2025 to shareholders of record on August 15, 2025. CASH FLOWS AND LIQUIDITY Our consolidated cash provided by operating activities for the six months ended June 30, 2025 was $159.4 million compared to $223.5 million for the six months ended June 30, 2024, with the decrease primarily due to the timing of fuel cost and rider recoveries from our utility customers and the timing of payments for operating costs, as well as a decrease in earnings. Investing activities for the six months ended June 30, 2025 included capital expenditures of $124.2 million. Capital expenditures during the period were largely within our Electric segment, including investments in wind repowering, advanced metering infrastructure, and transmission line projects. Financing activities for the six months ended June 30, 2025 included the issuance of $100.0 million of long-term debt at Otter Tail Power; the proceeds of which were used to repay short-term borrowings, fund capital investments, and support operating activities. Financing activities for the six months ended June 30, 2025 also included net repayments of short-term borrowings totaling $69.6 million and dividend payments of $44.0 million. As of June 30, 2025, we had $170.0 million and $211.0 million of available liquidity under our Otter Tail Corporation and Otter Tail Power credit facilities, respectively, along with $307.2 million of available cash and cash equivalents, for total available liquidity of $688.2 million. Electric Segment The following table shows heating and cooling degree days as a percent of normal. Three Months Ended June 30, 2025 2024 Heating Degree Days 86.5% 68.8% Cooling Degree Days 114.2% 48.8% Expand The following table summarizes the estimated effect on diluted earnings per share of the difference in retail kilowatt-hour (kwh) sales under actual weather conditions and expected retail kwh sales under normal weather conditions for the three months ended June 30, 2025 and 2024. Operating Revenues increased $15.9 million primarily due to increases in fuel recovery and rider revenues, and the impact of favorable weather compared to the same period last year. Increased fuel recovery revenue was primarily driven by an increase in the price of natural gas and the cost of market energy. Increased rider revenue was largely from the recovery of our investments in our wind repowering projects. Net Income increased $0.7 million primarily due to the increase in revenues, as described above, partially offset by increased operating and maintenance expenses, including planned outage costs at Coyote Station, and increased depreciation and interest expense associated with our rate base investments. Manufacturing Segment Operating Revenues decreased $18.0 million primarily due to a 9% decrease in sales volumes, with declines experienced across several end markets, including agriculture, recreational vehicles, lawn and garden, and construction. Sales volumes were down at our metal fabrication business due to soft end market demand and inventory management efforts by manufacturers and dealers. A 7% decrease in steel costs, which are passed through to customers, also contributed to the decrease in operating revenues. Net Income decreased $3.4 million primarily due to lower sales volumes and enhanced profit margins in the second quarter of 2024, which benefited from the positive impact of the timing of pass-through steel cost fluctuations and the selling of lower cost inventory. The impacts of decreased operating revenues and profit margins were partially offset by a decrease in general and administrative costs. Plastics Segment Operating Revenues decreased $7.2 million primarily due to a 15% decrease in sales prices compared to the same period last year, continuing the steady decline in product pricing from peak market conditions in late 2022. The impact of decreased sales prices was partially offset by an 11% increase in sales volumes, driven by strong distributor and end-market demand for our products, coupled with increased production capacity following the completion of our expansion project at Vinyltech in late 2024. Active infrastructure investment and construction activity across our sales territories continue to contribute to strong demand for our products. Net Income decreased $7.5 million primarily due to decreased sales prices, as described above, partially offset by the 11% increase in sales volumes and a 15% decrease in PVC resin cost driven by global supply and demand dynamics which continues to result in elevated supply. Corporate Net Income increased $0.9 million primarily due to increased market-based gains on our corporate-owned life insurance policy investments. 2025 OUTLOOK We are increasing our 2025 diluted earnings per share guidance to a range of $6.06 to $6.46. We expect our earnings mix in 2025 to be approximately 37% from our Electric segment and 63% from our Manufacturing and Plastics segments, net of corporate costs. Our anticipated earnings mix in 2025 deviates from our long-term expected earnings mix of 65% Electric / 35% Non-Electric as we expect Plastics segment earnings to remain elevated in 2025 compared to our long-term view of normal earnings for this segment. The segment components of our 2025 diluted earnings per share guidance compared with actual earnings for 2024 are as follows: We are maintaining our earnings guidance for our Electric and Manufacturing segments and maintaining our Corporate cost outlook. We are increasing our Plastics segment earnings guidance based on: Better than expected financial results in the second quarter of 2025, Lower material costs anticipated for the remainder of the year, as the forecasted price of PVC resin has declined, and Revised expectations for PVC pipe pricing for the second half of the year. CONFERENCE CALL AND WEBCAST The corporation will host a live webcast on Tuesday, August 5, 2025, at 10:00 a.m. CT to discuss its financial and operating performance. The presentation will be posted on our website before the webcast. To access the live webcast, go to and select 'Webcast.' Please allow time prior to the call to visit the site and download any software needed to listen in. An archived copy of the webcast will be available on our website shortly after the call. If you are interested in asking a question during the live webcast, visit and follow the link provided in the press release announcing the upcoming conference call. FORWARD-LOOKING STATEMENTS Except for historical information contained here, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The words 'anticipate,' 'believe,' 'can,' 'could,' 'estimate,' 'expect,' 'future,' 'goal,' 'intend,' 'likely,' 'may,' 'opportunity,' 'outlook,' 'plan,' 'possible,' 'potential,' 'predict,' 'probable,' 'projected,' 'should,' 'target,' 'will,' 'would' and similar words and expressions are intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of management. Forward-looking statements made herein, which may include statements regarding 2025 earnings and earnings per share, long-term earnings, earnings per share growth and earnings mix, anticipated levels of energy generation from renewable resources, anticipated reductions in carbon dioxide emissions, future investments and capital expenditures, rate base levels and rate base growth, future raw materials costs, future raw materials availability and supply constraints, future operating revenues and operating results, and expectations regarding regulatory proceedings, as well as other assumptions and statements, involve known and unknown risks and uncertainties that may cause our actual results in current or future periods to differ materially from the forecasted assumptions and expected results. The Company's risks and uncertainties include, among other things, uncertainty of future investments and capital expenditures; rate base levels and rate base growth; risks associated with energy markets; the availability and pricing of resource materials; inflationary cost pressures; attracting and maintaining a qualified and stable workforce; changing macroeconomic and industry conditions that impact the demand for our products, pricing and margin; long-term investment risk; seasonal weather patterns and extreme weather events; future business volumes with key customers; reductions in our credit ratings; our ability to access capital markets on favorable terms; assumptions and costs relating to funding our employee benefit plans; our subsidiaries' ability to make dividend payments; cybersecurity threats or data breaches; the impact of government legislation and regulation including foreign trade policy and environmental; health and safety laws and regulations; changes in tax laws and regulations; the impact of climate change including compliance with legislative and regulatory changes to address climate change; expectations regarding regulatory proceedings, assigned service areas, the construction of major facilities, capital structure, and allowed customer rates; actual and threatened claims or litigation; and operational and economic risks associated with our electric generating and manufacturing facilities. These and other risks are more fully described in our filings with the Securities and Exchange Commission, including our most recently filed Annual Report on Form 10-K, as updated in subsequently filed Quarterly Reports on Form 10-Q, as applicable. Forward-looking statements speak only as of the date they are made, and we expressly disclaim any obligation to update any forward-looking information. Category: Earnings About the Corporation: Otter Tail Corporation, a member of the S&P SmallCap 600 Index, has interests in diversified operations that include an electric utility and manufacturing businesses. Otter Tail Corporation stock trades on the Nasdaq Global Select Market under the symbol OTTR. The latest investor and corporate information is available at Corporate offices are in Fergus Falls, Minnesota, and Fargo, North Dakota. OTTER TAIL CORPORATION CONSOLIDATED BALANCE SHEETS (unaudited) June 30, December 31, (in thousands) 2025 2024 Assets Current Assets Cash and Cash Equivalents $ 307,241 $ 294,651 Receivables, net of allowance for credit losses 180,823 145,964 Inventories 151,558 148,885 Regulatory Assets 8,946 9,962 Other Current Assets 25,842 30,579 Total Current Assets 674,410 630,041 Noncurrent Assets Investments 128,289 121,177 Property, Plant and Equipment, net of accumulated depreciation 2,754,068 2,692,460 Regulatory Assets 99,010 98,673 Intangible Assets, net of accumulated amortization 5,192 5,743 Goodwill 37,572 37,572 Other Noncurrent Assets 66,747 66,416 Total Noncurrent Assets 3,090,878 3,022,041 Total Assets $ 3,765,288 $ 3,652,082 Liabilities and Shareholders' Equity Current Liabilities Short-Term Debt $ — $ 69,615 Accounts Payable 98,234 113,574 Accrued Salaries and Wages 25,039 34,398 Accrued Taxes 16,465 17,314 Regulatory Liabilities 24,580 29,307 Other Current Liabilities 39,162 45,582 Total Current Liabilities 203,480 309,790 Noncurrent Liabilities and Deferred Credits Pension Benefit Liability 32,204 32,614 Other Postretirement Benefits Liability 26,494 27,385 Regulatory Liabilities 289,546 288,928 Deferred Income Taxes 278,091 267,745 Deferred Tax Credits 14,705 14,990 Other Noncurrent Liabilities 102,932 98,397 Total Noncurrent Liabilities and Deferred Credits 743,972 730,059 Commitments and Contingencies Capitalization Long-Term Debt 1,043,374 943,734 Shareholders' Equity Common Shares 209,522 209,140 Additional Paid-In Capital 432,664 429,089 Retained Earnings 1,131,542 1,029,738 Accumulated Other Comprehensive Income 734 532 Total Shareholders' Equity 1,774,462 1,668,499 Total Capitalization 2,817,836 2,612,233 Total Liabilities and Shareholders' Equity $ 3,765,288 $ 3,652,082 Expand OTTER TAIL CORPORATION CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) Six Months Ended June 30, (in thousands) 2025 2024 Operating Activities Net Income $ 145,827 $ 161,333 Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities: Depreciation and Amortization 58,822 52,528 Deferred Tax Credits (285 ) (372 ) Deferred Income Taxes 6,149 9,492 Investment Gains (2,741 ) (3,111 ) Stock Compensation Expense 7,396 6,824 Other, net (1,745 ) (1,251 ) Change in Operating Assets and Liabilities: Receivables (34,859 ) (34,803 ) Inventories (131 ) (11,551 ) Regulatory Assets (643 ) 7,361 Other Assets 4,756 (3,951 ) Accounts Payable (6,477 ) 41,239 Accrued and Other Liabilities (13,447 ) (19,312 ) Regulatory Liabilities 198 23,863 Pension and Other Postretirement Benefits (3,441 ) (4,828 ) Net Cash Provided by Operating Activities 159,379 223,461 Investing Activities Capital Expenditures (124,239 ) (175,528 ) Proceeds from Disposal of Noncurrent Assets 2,792 5,124 Purchases of Investments and Other Assets (5,579 ) (57,661 ) Net Cash Used in Investing Activities (127,026 ) (228,065 ) Financing Activities Net Repayments of Short-Term Debt (69,615 ) (68,612 ) Proceeds from Issuance of Long-Term Debt 100,000 120,000 Dividends Paid (44,023 ) (39,122 ) Payments for Shares Withheld for Employee Tax Obligations (3,134 ) (5,753 ) Other, net (2,991 ) (1,610 ) Net Cash (Used in) Provided by Financing Activities (19,763 ) 4,903 Net Change in Cash and Cash Equivalents 12,590 299 Cash and Cash Equivalents at Beginning of Period 294,651 230,373 Cash and Cash Equivalents at End of Period $ 307,241 $ 230,672 Expand OTTER TAIL CORPORATION Three Months Ended June 30, Six Months Ended June 30, Operating Revenues Electric $ 128,731 $ 112,828 $ 278,451 $ 254,317 Manufacturing 78,726 96,684 160,412 196,065 Plastics 125,586 132,824 231,533 239,022 Total Operating Revenues $ 333,043 $ 342,336 $ 670,396 $ 689,404 Operating Income (Loss) Electric $ 23,633 $ 22,597 $ 52,676 $ 51,639 Manufacturing 5,065 9,600 7,492 17,014 Plastics 72,034 82,089 130,909 145,392 Corporate (3,274 ) (3,375 ) (9,620 ) (8,159 ) Total Operating Income $ 97,458 $ 110,911 $ 181,457 $ 205,886 Net Income Electric $ 19,195 $ 18,485 $ 43,903 $ 40,956 Manufacturing 3,481 6,835 5,013 12,096 Plastics 53,104 60,612 96,543 107,350 Corporate 1,948 1,063 368 931 Total Net Income $ 77,728 $ 86,995 $ 145,827 $ 161,333 Expand

Epicor Helps Distributors in Australia and New Zealand Turn Insights into Action with Epicor Prophet 21 Cloud ERP
Epicor Helps Distributors in Australia and New Zealand Turn Insights into Action with Epicor Prophet 21 Cloud ERP

Business Wire

time18 minutes ago

  • Business Wire

Epicor Helps Distributors in Australia and New Zealand Turn Insights into Action with Epicor Prophet 21 Cloud ERP

SYDNEY--(BUSINESS WIRE)--Epicor, a global leader of industry-specific enterprise software to promote business growth, today continued its global portfolio expansion for the make, move, and sell industries with the upcoming release of Epicor Prophet 21 for distributors in Australia and New Zealand (ANZ). Epicor Prophet 21 is an industry-leading SaaS ERP solution tailored for distributors, and part of the Epicor Industry ERP Cloud. Distributors can leverage advanced business intelligence and industry-specific integrations to strengthen operations, supplier relationships, protect against cyber threats, and strengthen time-to-value. According to a new Forrester study in collaboration with Epicor, 78 percent of distributors across ANZ are planning to adopt or expand their use of AI in ERP, yet only 35 percent have implemented it meaningfully. This highlights a major gap between ambition and execution, with legacy ERP systems and siloed data cited as the top barriers to supply chain agility and modernisation. In addition, by 2028 68 percent of distributors in ANZ plan to change their ERP solution, with many already evaluating alternatives. This signals a major shift towards modern, SaaS-based ERP platforms. 'We've listened closely to the needs of distributors in Australia and New Zealand and are responding with increased resources and tailored solutions to meet their needs,' said Andy Coussins, Executive Vice President of International at Epicor. 'Our expansion in this key market reflects our long-term global commitment and focus on providing distributors the SaaS-based, data-driven capabilities they need to make smarter, faster decisions.' The upcoming release of Epicor Prophet 21 in ANZ, slated for December 2025, emphasises enhanced Country-Specific Functionality (CSF), addressing the unique needs and regulatory requirements of businesses within the region. These new regional capabilities are not only designed to strengthen compliance with local regulations but also enhance operational effectiveness and customer engagement through customisable forms and languages. Expected features include: Robust compliance with local accounting standards such as IFRS and GAAP, as well as streamlined management of Goods and Services Tax (GST). Extensive Business Activity Statement (BAS) reporting capabilities to assist in fulfilling tax obligations, as well as adherence to the Payment Times Reporting Scheme (PTRS) which promotes fair payment practices to small business suppliers. Integration of BPAY which allows for convenient electronic payments through financial institutions, significantly improving transaction efficiency. For more information or to schedule a demo of Epicor Prophet 21, please visit our website. About Epicor Epicor Software Corporation equips hard-working businesses with enterprise solutions that keep the world turning. For more than 50 years, Epicor customers in the automotive, building supply, distribution, manufacturing, and retail industries have trusted Epicor to help them do business better. Innovative Epicor solution sets are carefully curated to fit customer needs and built to flexibly respond to their fast-changing reality. With deep industry knowledge and experience, Epicor accelerates its customers' ambitions, whether to grow and transform, or simply become more productive and effective. Visit for more information. Epicor and the Epicor logo are trademarks of Epicor Software Corporation, registered in the United States and other countries. Other trademarks referenced are the property of their respective owners. The product and service offerings depicted in this document are produced by Epicor Software Corporation. Results are not guaranteed, and each user's experience will vary.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store